KalVista Pharmaceuticals (4XC1.STU) Q4 2025 Earnings

10NovConfirmed
Q4 2025
-0.8
-0.72
-0.65
-0.58

Details

Expected EPS
-0.58154597442
Actual EPS
-0.7959012000000001
Surprise EPS
-0.21
Surprise Percent
+36.86%

Description

KalVista Pharmaceuticals (4XC1.STU) has reported earnings of -0.7959012000000001 per share for Q4 2025.

0 Comments

Share your thoughts